$79.79▴ 0.53%
End-of-day close · 2026-09-01
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
✦ The read
GRAIL, Inc.'s earnings-quality signal is not available yet.
Key numbers
Recent news
Sentiment · last 30 days2 articles
0 bullish2 neutral0 bearish
Grail Stock Hit a 12-Month High After Its FDA Panel Win. But Here's the Risk Investors Shouldn't Ignore.
3 Reasons to Buy Grail (GRAL) Hand Over Fist in OctoberPICS FINAL DEADLINE ALERT: PicS N.V. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before August 4, 2026 Deadline – Hagens Berman
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH